BiotechTube
Home/EnCompass Technologies/Carl Swindle
CS

Carl Swindle

VP R&D and Operations

EnCompass Technologies

Therapeutic Areas

CardiovascularNeurology

EnCompass Technologies Pipeline

DrugIndicationPhase
F2 Cerebral Embolic Protection SystemPrevention of brain injury/stroke during Transcatheter Aortic Valve Replacement (TAVR)Pre-clinical

Leadership Team at EnCompass Technologies

GW
George Wallace
Founder and CEO
MJ
Mike Jones
Founder and VP of R&D
KC
Kathleen Calderon
Senior Director of Clinical
JW
Jeff Weinrich
VP Therapy Solutions
JE
Jen Epp
VP Marketing
View full EnCompass Technologies profile